INO Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $1.16

Capitalizzazione di Mercato (MRQ) $96M

P/E (TTM) -1.1

EPS (TTM) $-1.04

Ricavi (TTM) $0

ROE (TTM) -409.9%

Intervallo 52 sett. $1–$3

INO Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Split azionari 3

Data ex-dividendo	Split	Tipo
25 Gennaio 2024	1-for-12	Inverso
06 Giugno 2014	1-for-4	Inverso
13 Settembre 2004	1-for-4	Inverso

Informazioni su Inovio Pharmaceuticals, Inc. - Common Stock Panoramica della società da Wikipedia

05 · wikidata

Inovio Pharmaceuticals è un'azienda statunitense di biotecnologie fondata nel 1983, con sede a Plymouth Meeting in Pennsylvania. Quotata al NASDAQ, è attiva nella ricerca e nello sviluppo di prodotti a base di DNA sintetico per il trattamento di tumori e malattie infettive e nei vaccini.

Fonte: Wikipedia, CC BY-SA 4.0 · Vedi su Wikipedia ↗

Wikidata ↗

settoreHealthcare industriaBiotechnology dipendenti112 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

Ricavi$65.3K

2016-12-31 → 2025-12-31

EPS$-1.81

2016-12-31 → 2025-12-31

Flusso di cassa libero$-89M

2016-12-31 → 2025-12-31

Margine netto-130000.0%

2016-12-31 → 2025-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	INO	media 5 anni	Mediana dei peer	Verdetto
P/E (TTM)	-1.1media 5 anni ≈-1.4	≈-1.4	·	·
P/S	1224.9media 5 anni ≈2020.9	≈2020.9	232.7	Sopravvalutato
P/B (MRQ)	21.9media 5 anni ≈12.2	≈12.2	2.8	Sopravvalutato
Prezzo / FCF (TTM)	-1.2media 5 anni ≈-17.0	≈-17.0	·	·
Prezzo / Flusso di cassa (TTM)	-1.2media 5 anni ≈-17.1	≈-17.1	·	·
Price / Tangible Book (Prezzo / Valore contabile tangibile)	3.3media 5 anni ≈12.7	≈12.7	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	INO	media 5 anni	Mediana dei peer	Verdetto
Operating Margin (Margine Operativo)	-132871.3%media 5 anni ≈-44273.6%	≈-44273.6%	-1300.3%	Debole
EBITDA Margin (Margine EBITDA)	-132871.3%media 5 anni ≈-44273.6%	≈-44273.6%	-1300.3%	Debole
Pretax Margin (Margine ante imposte)	-130000.0%media 5 anni ≈-43057.0%	≈-43057.0%	-2475.3%	Debole
Net Profit Margin (Margine di Profitto Netto)	-130000.0%media 5 anni ≈-43066.1%	≈-43066.1%	-2227.9%	Debole
ROA (TTM)	-114.6%media 5 anni ≈-68.6%	≈-68.6%	-45.0%	Debole
ROE (TTM)	-409.9%media 5 anni ≈-153.0%	≈-153.0%	-103.7%	Debole
ROIC	-360.3%media 5 anni ≈-168.6%	≈-168.6%	-93.3%	Debole

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	Tendenza 5 anni	INO	media 5 anni	Mediana dei peer	Verdetto
Rapporto corrente (MRQ)		1.0media 5 anni ≈3.6	≈3.6	5.0	Bassa liquidità
Quick Ratio		1.3media 5 anni ≈3.3	≈3.3	3.3	Bassa liquidità

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	INO	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)	-70.0%media 5 anni ≈33.3%	≈33.3%	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)	-81.5%media 5 anni ≈-61.2%	≈-61.2%	·	·
Revenue CAGR 5Y (CAGR Ricavi 5Y)	-61.2%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	INO	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-1.81media 5 anni ≈$-8.67	≈$-8.67	·	·
Revenue / Share (Ricavi / Azione)	$0.00media 5 anni ≈$0.02	≈$0.02	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-1.89media 5 anni ≈$-2.65	≈$-2.65	·	·
Cash / Share (Liquidità / Azione)	$0.64media 5 anni ≈$0.72	≈$0.72	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	INO	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)	0.0media 5 anni ≈0.0	≈0.0	0.0	Debole
Receivables Turnover (Rotazione dei crediti)	0.1media 5 anni ≈0.8	≈0.8	5.9	Debole
Revenue / Employee (Ricavi / Dipendente)	≈$583.42	·	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media 24.6%

Prossimo report Nov 09, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Ago 10, 2026	$-0.07	$-0.22	68.0%
31 Marzo 2026	Mag 11, 2026	$-0.28	$-0.35	20.8%
31 Dicembre 2025		$0.06	$-0.36	116.6%
30 Settembre 2025		$-0.87	$-0.43	-103.6%
30 Giugno 2025		$-0.61	$-0.62	0.86%
31 Marzo 2025		$-0.41	$-0.75	45.0%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 16

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$65.3K	$217.8K	$832.0K	$10M	$2M	$7M	$4M	$30M	$42M	$35M	$41M	$10M
R&D Expense	$54M	$76M	$87M	$188M	$249M	$94M	$88M	$95M	$99M	$89M	$58M	$34M
SG&A Expense	$33M	$37M	$48M	$90M	$54M	$37M	$27M	$29M	$28M	$24M	$18M	$16M
Operating Expenses	$87M	$113M	$145M	$278M	$303M	$131M	$115M	$125M	$126M	$112M	$75M	$50M
Operating Income	$-87M	$-112M	$-144M	$-268M	$-301M	$-124M	$-111M	$-94M	$-84M	$-76M	$-34M	$-39M
Interest Expense	·	·	$1M	$1M	$2M	$9M	$8M	$0	$25.9K	·	·	·
Interest Income	$2M	$5M	$8M	$5M	$3M	$3M	$3M	$2M	$2M	·	·	·
Other Non-op	$-3M	$-3M	$-5M	$-4M	$343.4K	$-704.9K	$496.2K	$-1M	$-197.5K	·	·	·
Pretax Income	$-85M	$-107M	$-135M	$-278M	$-303M	$-163M	$-121M	$-95M	$-88M	$-74M	$-31M	$-36M
Income Tax	$0	$0	$0	$0	$0	$0	$-257.3K	$2M	$0	$0	$-2M	$0
Net Income	$-85M	$-107M	$-135M	$-280M	$-304M	$-166M	$-119M	$-97M	$-88M	$-74M	$-29M	$-36M
EPS (Basic)	$-1.81	$-3.95	$-6.09	$-14.07	$-17.45	$-1.07	$-1.21	$-1.05	$-1.08	$-1.01	$-0.43	$-0.61
EPS (Diluted)	$-1.81	$-3.95	$-6.09	$-14.07	$-17.45	$-1.07	$-1.21	$-1.05	$-1.09	$-1.01	$-0.44	$-0.64
Shares (Basic)	46,886,413	27,160,863	22,173,662	19,885,182	17,402,483	155,126,857	98,717,999	92,539,997	81,777,493	73,214,766	68,198,142	59,127,349
Shares (Diluted)	46,886,413	27,160,863	22,173,662	19,885,182	17,402,483	155,126,857	98,717,999	92,539,997	81,918,022	73,214,766	68,365,265	59,408,252
EBITDA	$-87M	$-112M	$-144M	$-268M	$-301M	$-124M	$-111M	$-94M	$-84M	$-76M	$-34M	$-39M

Stato Patrimoniale 27

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$44M	$66M	$14M	$46M	$71M	$251M	$22M	$24M	$24M	$19M	$58M	$41M
Short-term Investments	$14M	$28M	$131M	$207M	$330M	$161M	$67M	$58M	$104M	$86M	$105M	$53M
Receivables	$450	$1M	$2M	$2M	$5M	$19M	$700.1K	$3M	$6M	$16M	$7M	$3M
Prepaid Expense	$3M	$4M	$5M	$50M	$39M	$40M	$2M	$1M	$3M	$2M	$917.3K	$798.0K
Current Assets	$61M	$98M	$153M	$315M	$448M	$471M	$94M	$88M	$138M	$125M	$172M	$99M
PP&E (Net)	$3M	$4M	$5M	$8M	$17M	$11M	$13M	$16M	$18M	$9M	$7M	$5M
PP&E (Gross)	$20M	$20M	$26M	$29M	$36M	$27M	$26M	$26M	$25M	$14M	$11M	$7M
Accum. Depreciation	$17M	$16M	$21M	$22M	$19M	$16M	$13M	$10M	$7M	$5M	$4M	$3M
Goodwill	·	·	$0	$11M	$11M	$11M	$11M	$11M	$11M	$11M	$10M	$10M
Intangibles	·	·	$0	$2M	$3M	$3M	$4M	$5M	$6M	$8M	$4M	$5M
Other Non-current Assets	$2M	$2M	$605.3K	$684.0K	$1M	$26M	$3M	$3M	$3M	$2M	$670.8K	$474.6K
Total Assets	$74M	$113M	$171M	$349M	$496M	$540M	$144M	$131M	$187M	$174M	$214M	$132M
Accounts Payable	·	·	·	$80M	$48M	$21M	$18M	$23M	$23M	$20M	$13M	$6M
Accrued Liabilities	·	·	·	·	·	·	·	$6M	$9M	$6M	$3M	$2M
Current Liabilities	$44M	$35M	$43M	$97M	$66M	$42M	$32M	$35M	$35M	$44M	$31M	$14M
Capital Leases	$7M	$9M	$11M	$13M	$15M	$18M	$20M	·	·	·	·	·
Deferred Tax	·	·	$0	$32.0K	$32.0K	$32.0K	$32.0K	$24.8K	$24.8K	$174.8K	$175.6K	$504.0K
Other Non-current Liabilities	·	·	·	$0	$14.8K	$57.7K	$36.9K	$87.3K	$0	·	·	·
Total Liabilities	$50M	$45M	$54M	$126M	$96M	$79M	$139M	$44M	$45M	$50M	$38M	$20M
Long-term Debt	·	·	·	·	·	·	·	$0	·	·	·	·
Common Stock	$69.0K	$36.1K	$22.8K	$21.1K	$217.4K	$186.9K	$101.4K	$97.2K	$90.4K	$74.1K	$72.2K	$60.7K
Paid-in Capital	$1.84B	$1.80B	$1.74B	$1.71B	$1.61B	$1.37B	$743M	$708M	$666M	$557M	$534M	$443M
Retained Earnings	$-1.82B	$-1.73B	$-1.62B	$-1.49B	$-1.21B	$-906M	$-740M	$-620M	$-523M	$-435M	$-361M	$-332M
AOCI	$-638.0K	$-675.7K	$-662.6K	$-698.7K	$-282.2K	$-256.1K	$472.6K	$-528.9K	$-117.0K	$1M	$3M	$-251.4K
Stockholders' Equity	$24M	$69M	$117M	$222M	$400M	$461M	$3M	$87M	$142M	$123M	$176M	$111M
Liabilities + Equity	$74M	$113M	$171M	$349M	$496M	$540M	$144M	$131M	$187M	$174M	$214M	$132M
Shares Outstanding	68,996,647	36,099,991	22,793,075	21,090,938	217,382,887	186,851,493	101,361,034	97,225,810	90,357,644	74,062,370	72,217,965	60,741,082

Flusso di cassa 14

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Stock-based Comp	$4M	$7M	$11M	$23M	$26M	$16M	$11M	$11M	$13M	$10M	$6M	$5M
Deferred Tax	·	$0	$-32.0K	$0	$0	$0	$-263.0K	$0	$0	$0	$-2M	$27.0K
Amort. of Intangibles	·	$0	$145.4K	$496.5K	$520.4K	$547.1K	$1M	$1M	$2M	$1M	$870.2K	$942.7K
Operating Cash Flow	$-89M	$-104M	$-124M	$-216M	$-216M	$-178M	$-98M	$-74M	$-63M	$-63M	$-12M	$-30M
CapEx	$285.7K	$487.8K	$320.9K	$969.2K	$1M	$2M	$987.9K	$2M	$10M	$3M	$3M	$1M
Investing Cash Flow	$14M	$104M	$87M	$110M	$-175M	$-59M	$-9M	$42M	$-28M	$16M	$-55M	$-36M
Debt Issued	·	·	·	·	$0	$0	$97M	$0	$0	·	·	·
Net Debt Issued	·	·	·	·	$0	$0	$97M	·	·	·	·	·
Stock Issued	$35M	$36M	$5M	$83M	$209M	$454M	$9M	$29M	$94M	$6M	$82M	$59M
Net Stock Activity	$35M	$36M	$5M	$83M	$209M	$454M	$9M	$29M	$94M	$6M	$82M	$59M
Financing Cash Flow	$53M	$51M	$5M	$82M	$211M	$465M	$105M	$31M	$96M	$8M	$84M	$72M
Net Change in Cash	$-22M	$52M	$-32M	$-25M	$-180M	$229M	$-1M	$-92.9K	$5M	$-38M	$17M	$7M
Free Cash Flow	$-89M	$-105M	$-125M	$-217M	$-217M	$-179M	$-99M	$-76M	$-74M	$-65M	$-15M	$-31M
Levered FCF	·	·	$-126M	$-218M	$-219M	$-188M	$-107M	·	·	·	·	·

Redditività 7

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Operating Margin	-132871.3%	-51616.9%	-17300.3%	-2607.3%	-16972.3%	-1674.2%	-2702.1%	-308.7%	-198.1%	-215.6%	-84.5%	-377.7%
Net Margin	-130000.0%	-49254.3%	-16239.9%	-2726.7%	-17109.9%	-2245.4%	-2902.8%	-318.1%	-208.9%	-208.5%	-71.9%	-345.4%
Pretax Margin	-130000.0%	-49254.3%	-16239.9%	-2705.6%	-17085.4%	-2197.9%	-2938.0%	-311.0%	-208.9%	-208.5%	-76.9%	·
EBITDA Margin	-132871.3%	-51616.9%	-17300.3%	-2607.3%	-16972.3%	-1674.2%	-2702.1%	-308.7%	-198.1%	-215.6%	-84.5%	-377.7%
ROA	-90.6%	-75.5%	-52.0%	-66.3%	-58.6%	-48.7%	-86.8%	-60.9%	-48.9%	-38.0%	-16.9%	-32.8%
ROE	-322.8%	-151.0%	-105.8%	-114.4%	-71.2%	-71.6%	-264.2%	-84.6%	-66.4%	-49.3%	-20.3%	-44.1%
ROIC	-360.3%	-164.1%	-122.7%	-120.3%	-75.4%	-26.9%	-3226.5%	-110.7%	-58.7%	-61.8%	-18.2%	·

Liquidità e Solvibilità 3

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	1.4	2.8	3.6	3.3	6.8	11.3	2.9	2.5	3.9	2.8	5.5	7.1
Quick Ratio	1.3	2.7	3.4	2.6	6.2	10.3	2.8	2.4	3.8	2.8	5.4	6.9
Interest Coverage	·	·	-117.7	-213.4	-155.6	-14.3	-14.0	·	·	·	·	·

Efficienza 2

Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.1
Receivables Turnover		0.1	0.1	·	2.9	0.1	0.8	2.0	6.5	3.9	3.1	8.0	3.4

Per Azione 5

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$0.35	$1.90	$5.15	$0.88	$1.84	$2.47	$0.03	$0.89	$1.58	$1.66	$2.43	$1.83
Revenue / Share	$0.00	$0.01	$0.04	$0.04	$0.01	·	$0.04	$0.33	$0.52	$0.48	$0.59	$0.18
Cash Flow / Share	$-1.89	$-3.83	$-5.61	$-0.91	$-1.03	·	$-0.99	$-0.79	$-0.77	$-0.85	$-0.18	$-0.50
Cash / Share	$0.64	$1.82	$0.63	$0.18	$0.33	$1.34	$0.22	$0.24	$0.26	$0.26	$0.80	$0.67
EPS (TTM)	$-1.81	$-3.95	$-6.09	$-14.07	$-17.45	$-1.07	$-1.21	$-1.05	$-1.09	$-1.01	$-0.44	$-0.64

Tassi di Crescita 3

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	-70.0%	-73.8%	-91.9%	478.2%	-76.0%	·	·	·	·	·	·	·
Revenue CAGR 3Y	-81.5%	-50.3%	-51.8%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	-61.2%	·	·	·	·	·	·	·	·	·	·	·

Valutazione (TTM) 10

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$65.3K	$217.8K	$832.0K	$10M	$2M	$7M	$4M	$30M	$42M	$35M	$41M	$10M
Net Income TTM	$-85M	$-107M	$-135M	$-280M	$-304M	$-166M	$-119M	$-97M	$-88M	$-74M	$-29M	$-36M
Market Cap	$120M	$66M	$139M	$4.74B	$13.02B	$19.84B	$4.01B	$4.67B	$4.48B	$6.17B	$5.82B	$6.69B
P/E	-1.0	-0.5	-1.0	-1.3	-3.4	-99.3	-32.7	-45.7	-45.5	-82.5	-183.3	-172.1
P/S	1837.3	303.4	167.7	461.7	7334.5	2677.5	976.2	153.1	106.1	174.4	143.5	639.9
P/B	5.0	1.0	1.2	21.3	32.6	43.0	1168.5	53.7	31.4	50.0	33.1	60.2
P / Tangible Book	5.0	1.0	1.2	22.6	33.7	44.3	·	·	·	·	·	·
P / Cash Flow	-1.4	-0.6	-1.1	-21.9	-60.3	-111.5	-41.0	-63.5	-70.8	-98.6	-468.2	-224.4
P / FCF	-1.4	-0.6	-1.1	-21.8	-60.0	-110.5	-40.6	-61.7	-60.9	-94.5	-382.6	-214.4
Earnings Yield	-104.0%	-215.9%	-99.5%	-75.2%	-29.1%	-1.0%	-3.1%	-2.2%	-2.2%	-1.2%	-0.55%	-0.58%

Conto Economico 15

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Revenue	$0	$0	$0	$0	$0	$65.3K	$117.0K	$0	$100.8K	$0	$388.4K	$226.0K	$114.9K	$9M	$784.4K	$199.1K
R&D Expense	$11M	$14M	$10M	$13M	$15M	$16M	$13M	$19M	$23M	$21M	$16M	$24M	$30M	$33M	$56M	$56M
SG&A Expense	$8M	$8M	$7M	$8M	$9M	$9M	$8M	$9M	$10M	$11M	$10M	$14M	$14M	$12M	$48M	$16M
Operating Expenses	$19M	$22M	$17M	$21M	$23M	$25M	$20M	$27M	$33M	$31M	$36M	$37M	$44M	$45M	$105M	$72M
Operating Income	$-19M	$-22M	$-17M	$-21M	$-23M	$-25M	$-20M	$-27M	$-33M	$-31M	$-36M	$-37M	$-44M	$-36M	$-104M	$-72M
Interest Expense	·	·	·	·	·	·	·	·	·	$177.8K	$313.5K	$313.5K	$313.5K	$313.5K	$313.5K	$313.5K
Interest Income	$363.8K	$439.6K	$449.3K	$552.1K	$610.6K	$808.1K	$852.6K	$1M	$1M	$2M	$2M	$2M	$2M	$1M	$857.7K	$669.8K
Other Non-op	$-2M	$-285.5K	$88	$-2M	$-703.2K	$-482	$-2M	$-579.8K	$7.6K	$-682.2K	$2.9K	$-1M	$-2M	$-940.8K	$-3.0K	$-153.5K
Pretax Income	·	·	·	·	·	·	·	·	·	·	$-34M	$-36M	$-41M	$-38M	$-108M	$-77M
Net Income	$-6M	$-20M	$4M	$-45M	$-24M	$-20M	$-19M	$-25M	$-32M	$-30M	$-34M	$-36M	$-41M	$-38M	$-108M	$-79M
EPS (Basic)	$-0.07	$-0.28	$0.18	$-0.87	$-0.61	$-0.51	$-0.56	$-0.89	$-1.19	$-1.31	$-1.52	$-1.61	$-1.89	$-0.15	$-0.46	$-0.36
EPS (Diluted)	$-0.07	$-0.28	$0.18	$-0.87	$-0.61	$-0.51	$-0.56	$-0.89	$-1.19	$-1.31	$-1.52	$-1.61	$-1.89	$-0.15	$-0.46	$-0.36
Shares (Basic)	81,619,113	69,101,910	·	52,168,694	38,830,053	38,613,653	·	28,140,497	27,197,802	23,291,512	22,385,229	22,029,486	21,536,476	249,351,023	235,278,276	218,940,693
Shares (Diluted)	81,619,113	69,101,910	·	52,168,694	38,830,053	38,613,653	·	28,140,497	27,197,802	23,291,512	22,385,229	22,029,486	21,536,476	249,351,023	235,278,276	218,940,693
EBITDA	$-19M	$-22M	·	$-21M	$-23M	$-25M	·	$-27M	$-33M	$-31M	$-36M	$-37M	$-44M	$-36M	$-104M	$-72M

Stato Patrimoniale 25

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Cash & Equivalents	$32M	$26M	$44M	$37M	$24M	$40M	$66M	$22M	$34M	$20M	$19M	$53M	$28M	$22M	$41M	$59M
Short-term Investments	$5M	$11M	$14M	$14M	$23M	$28M	$28M	$63M	$76M	$86M	$149M	$142M	$196M	$260M	$307M	$301M
Receivables	·	·	$450	$978.6K	$840.3K	$1M	$1M	$2M	$2M	$3M	·	·	$73.3K	$2M	$4M	$4M
Prepaid Expense	$3M	$2M	$3M	$3M	$4M	$2M	$4M	$5M	$5M	$4M	$5M	$3M	$5M	$58M	$56M	$32M
Current Assets	$40M	$39M	$61M	$55M	$53M	$72M	$98M	$91M	$118M	$112M	$175M	$203M	$234M	$350M	$416M	$400M
PP&E (Net)	$2M	$2M	$3M	$3M	$3M	$3M	$4M	$4M	$5M	$5M	$6M	$6M	$7M	$16M	$16M	$17M
PP&E (Gross)	·	·	$20M	·	·	·	$20M	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	·	$17M	·	·	·	$16M	·	·	·	·	·	·	·	·	·
Goodwill	·	·	·	·	·	·	·	·	·	·	$0	$11M	$11M	$11M	$11M	$11M
Intangibles	·	·	·	·	·	·	·	·	·	·	$0	$0	$2M	$2M	$2M	$2M
Other Non-current Assets	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$566.4K	$585.9K	$605.3K	$605.3K	$666.9K	$652.5K	$702.0K	$770.1K	$1M
Total Assets	$49M	$50M	$74M	$69M	$68M	$87M	$113M	$107M	$134M	$129M	$193M	$233M	$267M	$392M	$459M	$446M
Accounts Payable	·	·	·	·	·	·	·	·	·	·	·	·	$25M	$74M	$105M	$38M
Current Liabilities	$40M	$38M	$44M	$70M	$32M	$27M	$35M	$23M	$26M	$23M	$44M	$52M	$55M	$95M	$131M	$59M
Capital Leases	$5M	$6M	$7M	$7M	$8M	$9M	$9M	$10M	$11M	$11M	$11M	$12M	$12M	$13M	$14M	$15M
Deferred Tax	·	·	·	·	·	·	·	·	·	·	$32.0K	$32.0K	$32.0K	$32.0K	$32.0K	$32.0K
Other Non-current Liabilities	·	·	·	·	·	·	·	·	·	·	·	·	·	$710.3K	$0	$0
Total Liabilities	$45M	$44M	$50M	$77M	$40M	$36M	$45M	$34M	$37M	$35M	$55M	$64M	$67M	$125M	$162M	$90M
Common Stock	$82.3K	$69.8K	$69.0K	$53.6K	$36.7K	$36.7K	$36.1K	$26.1K	$26.0K	$23.4K	$269.7K	$268.1K	$262.7K	$249.5K	$247.5K	$226.5K
Paid-in Capital	$1.85B	$1.84B	$1.84B	$1.81B	$1.80B	$1.80B	$1.80B	$1.78B	$1.78B	$1.75B	$1.74B	$1.73B	$1.73B	$1.70B	$1.69B	$1.64B
Retained Earnings	$-1.84B	$-1.83B	$-1.82B	$-1.82B	$-1.77B	$-1.75B	$-1.73B	$-1.71B	$-1.69B	$-1.65B	$-1.60B	$-1.56B	$-1.53B	$-1.43B	$-1.40B	$-1.29B
AOCI	$-280.0K	$-636.1K	$-638.0K	$-647.4K	$-661.7K	$-661.3K	$-675.7K	$-623.5K	$-689.5K	$-676.2K	$-751.1K	$-691.3K	$-582.8K	$-885.2K	$-649.7K	$-457.9K
Stockholders' Equity	$4M	$6M	$24M	$-8M	$29M	$51M	$69M	$74M	$97M	$94M	$138M	$169M	$199M	$267M	$298M	$355M
Liabilities + Equity	$49M	$50M	$74M	$69M	$68M	$87M	$113M	$107M	$134M	$129M	$193M	$233M	$267M	$392M	$459M	$446M
Shares Outstanding	82,341,945	69,773,237	68,996,647	53,571,675	36,718,527	36,674,355	36,099,991	26,052,452	25,963,544	23,371,253	269,731,481	268,073,202	262,739,126	249,485,264	247,504,547	226,510,720

Flusso di cassa 10

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Stock-based Comp	$768.4K	$698.7K	$764.6K	$757.1K	$834.8K	$1M	$1M	$1M	$2M	$3M	$2M	$3M	$4M	$3M	$8M	$8M
Amort. of Intangibles	·	·	·	·	·	·	·	$0	$0	$0	$0	$63.3K	$82.1K	$120.0K	$131.0K	$126.8K
Operating Cash Flow	$-18M	$-22M	$-19M	$-22M	$-21M	$-27M	$-20M	$-27M	$-28M	$-29M	$-29M	$-32M	$-37M	$-67M	$-51M	$-62M
CapEx	$0	$0	$127.4K	$68.0K	$30.9K	$59.4K	$0	$0	$452.3K	$35.6K	$0	$23.9K	$297.0K	$86.8K	$717.2K	$0
Investing Cash Flow	$6M	$3M	$-58.2K	$9M	$5M	$-51.8K	$35M	$14M	$10M	$45M	$-5M	$54M	$19M	$45M	$-10M	$21M
Stock Issued	$3M	$1M	$27M	$7M	$0	$1M	$13M	$667.1K	$17M	$5M	$708.3K	$3M	$0	$4M	$43M	$29M
Net Stock Activity	·	$1M	·	·	·	$1M	·	·	·	$5M	·	·	$0	·	·	$29M
Financing Cash Flow	$17M	$953.8K	$27M	$25M	$-34.8K	$1M	$29M	$660.6K	$33M	$-11M	$698.6K	$3M	$-424.7K	$4M	$43M	$28M
Net Change in Cash	$5M	$-18M	$8M	$12M	$-16M	$-26M	$44M	$-13M	$15M	$5M	$-34M	$24M	$-18M	$-19M	$-18M	$-12M
Free Cash Flow	·	$-22M	·	·	·	$-27M	·	·	·	$-29M	·	·	$-37M	·	·	$-62M

Redditività 6

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Operating Margin	·	·	·	·	·	-38337.0%	·	·	-32945.9%	·	-9152.6%	-16392.0%	-38238.2%	-390.6%	-13276.1%	-36033.3%
Net Margin	·	·	·	·	·	-30140.5%	·	·	-31993.3%	·	-8734.8%	-15725.3%	-35364.8%	-412.8%	-13832.0%	-39720.8%
Pretax Margin	·	·	·	·	·	·	·	·	·	·	-8734.8%	-15725.3%	-35364.8%	-412.8%	-13832.0%	-38633.1%
EBITDA Margin	·	·	·	·	·	-38337.0%	·	·	-32945.9%	·	-9152.6%	-16392.0%	-38238.2%	-390.6%	-13276.1%	-36033.3%
ROA	-10.2%	-28.7%	·	-51.6%	-23.3%	-18.2%	·	-16.8%	-17.6%	-15.4%	-11.6%	-10.3%	-11.4%	-8.2%	-20.6%	-14.4%
ROE	-36.5%	-68.7%	·	-138.2%	-37.5%	-27.0%	·	-23.8%	-24.2%	-20.8%	-16.8%	-15.2%	-14.7%	-10.5%	-26.9%	-16.9%

Liquidità e Solvibilità 3

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Current Ratio	1.0	1.0	·	0.8	1.7	2.6	·	3.9	4.5	4.8	4.0	3.9	4.2	3.7	3.2	6.7
Quick Ratio	0.9	1.0	·	0.7	1.5	2.5	·	3.7	4.2	4.6	3.8	3.8	4.1	3.0	2.7	6.1
Interest Coverage	·	·	·	·	·	·	·	·	·	-177.0	-113.4	-118.2	-140.2	-114.1	-332.2	-228.8

Efficienza 2

Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Asset Turnover		0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Receivables Turnover		·	·	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	·	0.1	2.5	0.1	0.0

Per Azione 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Book Value / Share	$0.05	$0.09	·	$-0.14	$0.78	$1.40	·	$2.82	$3.73	$4.04	$0.51	$0.63	$0.76	$1.07	$1.20	$1.57
Revenue / Share	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.04	$0.00	$0.00
Cash Flow / Share	·	$-0.31	·	·	·	$-0.70	·	·	·	$-1.23	·	·	$-0.14	·	·	$-0.28
Cash / Share	$0.38	$0.38	·	$0.68	$0.66	$1.09	·	$0.83	$1.32	$0.84	$0.07	$0.20	$0.11	$0.09	$0.17	$0.26
EPS (TTM)	$-1.04	$-1.58	·	$-2.55	$-2.57	$-3.15	·	·	·	·	·	·	·	$-17.47	$-17.61	$-17.54

Valutazione (TTM) 9

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Revenue TTM	$0	$0	·	$182.3K	$182.3K	$283.1K	·	·	·	·	·	·	·	$11M	$2M	$2M
Net Income TTM	$-67M	$-85M	·	$-108M	$-88M	$-96M	·	·	·	·	·	·	·	$-332M	$-355M	$-328M
Market Cap	$91M	$121M	·	$125M	$75M	$60M	·	$151M	$210M	$324M	$1.26B	$1.45B	$2.59B	$5.18B	$5.14B	$9.76B
P/E	-1.1	-1.1	·	-0.9	-0.8	-0.5	·	·	·	·	·	·	·	-1.2	-1.2	-2.5
P/S	·	·	·	687.5	410.8	211.2	·	·	·	·	·	·	·	471.8	2430.2	6088.5
P/B	20.7	20.0	·	-16.2	2.6	1.2	·	2.0	2.2	3.4	9.1	8.5	13.0	19.4	17.3	27.5
P / Tangible Book	20.7	20.0	·	·	2.6	1.2	·	2.0	2.2	3.4	9.1	9.1	13.9	20.4	18.0	28.5
P / Cash Flow	·	-5.6	·	·	·	-2.2	·	·	·	-11.3	·	·	-70.5	·	·	-157.7
Earnings Yield	-94.5%	-90.8%	·	-109.0%	-126.0%	-193.2%	·	·	·	·	·	·	·	-84.2%	-84.8%	-40.7%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$65.3K	$217.8K	$832.0K	$10M	$2M
Margine Operativo %	-132871.3%	-51616.9%	-17300.3%	-2607.3%	-16972.3%
Utile netto	$-85M	$-107M	$-135M	$-280M	$-304M
EPS Diluito	$-1.81	$-3.95	$-6.09	$-14.07	$-17.45

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rapporto corrente	1.4	2.8	3.6	3.3	6.8
Quick Ratio	1.3	2.7	3.4	2.6	6.2

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-89M	$-105M	$-125M	$-217M	$-217M

Proprietari istituzionali (13F) 115 filer · $44.9M totale · Aggiornato al 30 Giugno 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 115

Valore detenuto $44.9M

Nuove posizioni 22

Posizioni chiuse 15

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
22 (+3 vs trimestre precedente)	15 (+2 vs trimestre precedente)	33 (+11 vs trimestre precedente)	16 (-10 vs trimestre precedente)	-1.4M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
FMR LLC	$9.300.277	8.454.797	20,70%	Azioni
JANUS HENDERSON GROUP PLC	$5.773.168	3.308.406	12,85%	Azioni
VANGUARD GROUP INC	$5.769.110	3.315.580	12,84%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$4.015.618	3.650.562	8,94%	Azioni
Boxer Capital Management, LLC	$3.129.493	2.844.994	6,96%	Azioni
ADAR1 Capital Management, LLC	$2.358.301	2.143.910	5,25%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$1.672.440	1.520.400	3,72%	Opzione Call
D. E. Shaw & Co., Inc.	$1.486.822	1.351.656	3,31%	Azioni
TWO SIGMA INVESTMENTS, LP	$1.363.756	1.239.778	3,03%	Azioni
Eversept Partners, LP	$1.138.896	1.035.360	2,53%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$883.749	802.751	1,97%	Azioni
MILLENNIUM MANAGEMENT LLC	$875.718	796.107	1,95%	Azioni
BlackRock, Inc.	$856.963	779.057	1,91%	Azioni
VANGUARD FIDUCIARY TRUST CO	$528.846	480.769	1,18%	Azioni
Caption Management, LLC	$526.845	478.950	1,17%	Azioni
Caption Management, LLC	$440.000	400.000	0,98%	Opzione Call
RENAISSANCE TECHNOLOGIES LLC	$397.473	361.339	0,88%	Azioni
STATE STREET CORP	$370.271	336.610	0,82%	Azioni
CITADEL ADVISORS LLC	$351.450	319.500	0,78%	Opzione Call
TUDOR INVESTMENT CORP ET AL	$330.000	300.000	0,73%	Opzione Call
DIADEMA PARTNERS LP	$302.720	275.200	0,67%	Opzione Call
UBS Group AG	$288.552	262.320	0,64%	Azioni
Quadrature Capital Ltd	$284.821	258.928	0,63%	Azioni
CITADEL ADVISORS LLC	$265.952	241.775	0,59%	Azioni
NORTHERN TRUST CORP	$191.833	174.394	0,43%	Azioni
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$190.300	173.000	0,42%	Azioni
NOMURA HOLDINGS INC	$165.000	150.000	0,37%	Azioni
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main	$147.012	133.648	0,33%	Azioni
GMT Capital Corp	$138.731	126.119	0,31%	Azioni
JANE STREET GROUP, LLC	$136.977	124.525	0,30%	Azioni
TWO SIGMA ADVISERS, LP	$128.240	73.701	0,29%	Azioni
XTX Topco Ltd	$116.416	105.833	0,26%	Azioni
GOLDMAN SACHS GROUP INC	$103.092	93.720	0,23%	Azioni
CITADEL ADVISORS LLC	$92.620	84.200	0,21%	Opzione Put
Invesco Ltd.	$88.372	80.338	0,20%	Azioni
Green Alpha Advisors, LLC	$74.861	68.055	0,17%	Azioni
JANE STREET GROUP, LLC	$71.940	65.400	0,16%	Opzione Call
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$63.690	57.900	0,14%	Opzione Put
MORGAN STANLEY	$55.283	50.256	0,12%	Azioni
RAYMOND JAMES FINANCIAL INC	$46.515	42.286	0,10%	Azioni
Squarepoint Ops LLC	$40.030	36.391	0,09%	Azioni
Engineers Gate Manager LP	$37.060	33.691	0,08%	Azioni
Vanguard Global Advisers, LLC	$33.259	30.235	0,07%	Azioni
Headlands Technologies LLC	$32.878	29.889	0,07%	Azioni
ZACKS INVESTMENT MANAGEMENT	$29.079	26.435	0,06%	Azioni
Persistent Asset Partners Ltd	$22.160	701	0,05%	Opzione Call
Prime Capital Investment Advisors, LLC	$18.839	17.126	0,04%	Azioni
LPL Financial LLC	$18.826	17.114	0,04%	Azioni
StoneX Group Inc.	$18.077	14.252	0,04%	Azioni
TWO SIGMA SECURITIES, LLC	$17.554	15.958	0,04%	Azioni

Mostra tutti i 115 proprietari istituzionali →

Attivisti e proprietari del 5%+ 2 partecipazioni

18

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
Dr. J. Joseph Kim	10 Giugno 2009	·	Deposito iniziale	·	SEC
Simon Benito, Tee Khiang Ng and Morton Collins, Voting Trustees Under Voting Trust Agreement Dated June 1, 2009 among the Issuer, the Voting Trustees and the Stockholders listed therein.	10 Giugno 2009	·	Deposito iniziale	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Insider aziendali 42 insider · 12 dirigenti · 24 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Netto 12m
Jacqueline Elizabeth Shea	Chief Executive Officer	20 Maggio 2026 A	111.021	$0
Jong Joseph Kim	Chief Executive Officer	11 Marzo 2022 M	1.422.627	$0
Niranjan Sardesai	Chief Operating Officer	10 Marzo 2018 M	123.486	$0
Michael John Sumner	Chief Medical Officer	20 Maggio 2026 A	42.038	$0
Laurent Humeau	Chief Scientific Officer	20 Maggio 2026 A	46.823	$0
Mark Bagarazzi	Chief Medical Officer	05 Marzo 2019 M	100.672	$0
Kevin Rassas	Sr. VP Business Development	16 Novembre 2009 M	726.088	$0
Cheryl Jo White	Chief Medical Officer	29 Giugno 2009 M	·	$0
Dietmar P Rabussay	V.P. Research & Development	08 Marzo 2007 A	17.386	$0
Robert S Goodenew	V.P. Corporate Development	20 Dicembre 2006 M	·	$0
George F. Mchugh III	Vice President, Operations	08 Marzo 2006 A	1	$0
Brook G Riggins	V.P. Finance & Corp. Comm.	07 Novembre 2003 A	·	$0
Ann Calby Miller	Direttore	20 Maggio 2026 A	9.877	$0
Roger D Dansey	Direttore	20 Maggio 2026 A	8.916	$0
David B. Weiner	Direttore	20 Maggio 2026 A	87.592	$0
Jay Shepard	Direttore	20 Maggio 2026 A	9.209	$0
Wendy L Yarno	Direttore	20 Maggio 2026 A	10.512	$0
Angel Cabrera	Direttore	08 Maggio 2020 M	75.602	$0
Morton Collins	Direttore	11 Maggio 2019 M	168.130	$0
Avtar S Dhillon	Direttore	06 Dicembre 2018 M	106.002	$0
Adel Mahmoud	Direttore	12 Maggio 2018 M	22.669	$0
George Bickerstaff	Direttore	21 Marzo 2018 M	4.090	$0
Nancy Wysenski	Direttore	13 Maggio 2016 A	5.000	$0
Keith H Wells	Direttore	13 Maggio 2011 A	·	$0
David J Williams	Direttore	16 Giugno 2010 A	·	$0
Chin Cheong Chong	Direttore	09 Dicembre 2008 A	·	$0
James L Heppell	Direttore	14 Agosto 2008 A	2	$0
Stephen Rietiker	Direttore	02 Maggio 2008 A	·	$0
Robert William Rieder	Direttore	02 Maggio 2008 A	·	$0
Riaz Amirali Bandali	Direttore	02 Maggio 2008 A	2	$0
Tazdin Esmail	Direttore	02 Maggio 2008 A	2	$0
Felix Theeuwes	Direttore	07 Giugno 2006 A	2	$0
Eugene A Larson	Direttore	13 Maggio 2005 A	3	$0
Gordon Politeski	Direttore	08 Agosto 2003 A	·	$0
MARXE AUSTIN W & GREENHOUSE DAVID M	Proprietario del 10%	03 Dicembre 2012 S	3.919.706	$0
Lota S. Zoth	·	20 Maggio 2026 A	8.726	$0
Simon X Benito	·	20 Maggio 2026 A	12.191	$0
Peter Kies	·	20 Maggio 2026 A	42.854	$0
Tee Khiang Ng	·	30 Settembre 2009 A	·	$0
Punit Dhillon	·	30 Settembre 2009 A	·	$0
Michael Fons	·	30 Settembre 2009 A	·	$0
Beng Lee Gan	·	02 Maggio 2008 A	·	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 4 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
QQQS · Invesco Exchange-Traded Fund Trust …	0,50%	94.431 SH	02 Ottobre 2026	Giornaliero
IWC · iShares Trust	0,02%	278.295 SH	11 Settembre 2026	Giornaliero
VXF · VANGUARD INDEX FUNDS	0,00%	963.325 SH	19 Agosto 2026	Giornaliero
VTI · VANGUARD INDEX FUNDS	0,00%	2.600.092 SH	19 Agosto 2026	Giornaliero

INO Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 8 analisti COMPRA

Target mediano $3.00 +158,6%

2 25,0% Acquisto forte

4 50,0% Compra

2 25,0% Mantieni

0 0,0% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

3 analisti · 2026-09-29

Target medio $3.17 +173,0%

← Sotto tutti i target Prezzo attuale $1.16

Basso$2.50 Media$3.17 Alto$4.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
INO	$120M	-1.0	-70.0%	-130000.0%	-322.8%	·
CRBU	$151M	-1.0	11.7%	-1327.4%	-102.8%	·
SPRB	$120M	-1.7	-51.3%	·	-139.9%	·
TNYA	$154M	-1.2	·	·	-81.2%	·
FHTX	$306M	-4.6	36.8%	-240.3%	80.2%	·
HURA	·	-1.2	·	·	·	·
VTVT	·	·	·	·	-70.4%	·
CRBP	$143M	-1.4	·	·	-60.8%	·
UNCY	$128M	-3.5	-29.0%	·	-113.9%	·
IMDX	$215M	-4.5	115.6%	-1238.5%	330.8%	56.7%

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

INO Inovio Pharmaceuticals, Inc. - Common Stock

INO Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

INO Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Informazioni su Inovio Pharmaceuticals, Inc. - Common Stock Panoramica della società da Wikipedia

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Proprietari istituzionali (13F) 115 filer · $44.9M totale · Aggiornato al 30 Giugno 2026

Attivisti e proprietari del 5%+ 2 partecipazioni

Insider aziendali 42 insider · 12 dirigenti · 24 direttori

Proprietà ETF Posseduti da 4 ETF

INO Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

Target Price a 12 Mesi

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi